Thank you very much, Presiding Officer. Can I just ask for a statement from the Cabinet Secretary for health, please? The first concerns the availability of Orkambi to treat cystic fibrosis sufferers in Wales. In his reply to my written question on 15 August this year, the Cabinet Secretary said this medicine was not available routinely due to its high costs and modest clinical benefits. He went on to say that the All Wales Medicines Strategy Group had not received a response from the manufacturers, Vertex, about a further appraisal. I am now advised that Vertex have made a submission, which is being reviewed by the group. Can I ask for a commitment from the Cabinet Secretary for health that he will make a statement as soon as possible after this review has been concluded so that sufferers of this pernicious disease are kept fully informed about the availability of Orkambi?

Secondly, could I ask when the Welsh Government will be in a position to say whether funding for the Welsh ambulance service’s falls response team initiative will continue, since the pilot scheme ended on 13 March this year? Thank you.